Barnard DL - Search Results

1

Prosthetic vascular conduit in contaminated fields: a new technology to decrease ePTFE infections.

Fischer PE, Fabian TC, deRijk WG, Edwards NM, DeCuypere M, Landis RM, Barnard DL, Magnotti LJ, Croce MA. Fischer PE, et al. Among authors: barnard dl. Am Surg. 2008 Jun;74(6):524-8; discussion 528-9. Am Surg. 2008. PMID: 18556995

2

Propofol Infusion Syndrome: Efficacy of a Prospective Screening Protocol.

Schroeppel TJ, Clement LP, Barnard DL, Guererro W, Ferguson MD, Sharpe JP, Magnotti LJ, Croce MA, Fabian TC. Schroeppel TJ, et al. Among authors: barnard dl. Am Surg. 2018 Aug 1;84(8):1333-1338. Am Surg. 2018. PMID: 30185312

3

Peritoneal Tuberculosis in a Middle-Aged Man.

Frankovitz JH, Penny KW, Barnard DL. Frankovitz JH, et al. Among authors: barnard dl. Am Surg. 2023 Nov;89(11):4863-4865. doi: 10.1177/00031348211011117. Epub 2021 Apr 13. Am Surg. 2023. PMID: 33847174 No abstract available.

4

Examining the interactions of Galahad™ compound with viruses to develop a novel inactivated influenza A virus vaccine.

Barnard DL, Belnap DM, Azadi P, Heiss C, Snyder DS, Bock SC, Konowalchuk TW. Barnard DL, et al. Heliyon. 2022 Jul;8(7):e09887. doi: 10.1016/j.heliyon.2022.e09887. Epub 2022 Jul 6. Heliyon. 2022. PMID: 35821966 Free PMC article.

5

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B.

Warfield KL, Schaaf KR, DeWald LE, Spurgers KB, Wang W, Stavale E, Mendenhall M, Shilts MH, Stockwell TB, Barnard DL, Ramstedt U, Das SR. Warfield KL, et al. Among authors: barnard dl. Sci Rep. 2019 May 16;9(1):7484. doi: 10.1038/s41598-019-43030-y. Sci Rep. 2019. PMID: 31097731 Free PMC article.

6

Inhibition of adenovirus serotype 14 infection by octadecyloxyethyl esters of (S)-[(3-hydroxy-2-phosphonomethoxy)propyl]- nucleosides in vitro.

Kumaki Y, Woolcott JD, Roth JP, Mclean TZ, Smee DF, Barnard DL, Valiaeva N, Beadle JR, Hostetler KY. Kumaki Y, et al. Among authors: barnard dl. Antiviral Res. 2018 Oct;158:122-126. doi: 10.1016/j.antiviral.2018.08.004. Epub 2018 Aug 7. Antiviral Res. 2018. PMID: 30096340

7

Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.

Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL. Basu A, et al. Among authors: barnard dl. ACS Infect Dis. 2017 May 12;3(5):330-335. doi: 10.1021/acsinfecdis.6b00194. Epub 2017 Apr 3. ACS Infect Dis. 2017. PMID: 28301927 Free PMC article.

8

Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol^® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model.

Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Kumaki Y, et al. Among authors: barnard dl. Antiviral Res. 2017 Mar;139:1-12. doi: 10.1016/j.antiviral.2016.12.007. Epub 2016 Dec 9. Antiviral Res. 2017. PMID: 27956136 Free PMC article.

9

Activities of JNJ63623872 and oseltamivir against influenza A H1N1pdm and H3N2 virus infections in mice.

Smee DF, Barnard DL, Jones SM. Smee DF, et al. Among authors: barnard dl. Antiviral Res. 2016 Dec;136:45-50. doi: 10.1016/j.antiviral.2016.10.009. Epub 2016 Oct 19. Antiviral Res. 2016. PMID: 27771390

10

Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.

Vollmer AH, Gebre MS, Barnard DL. Vollmer AH, et al. Among authors: barnard dl. Antiviral Res. 2016 Sep;133:196-207. doi: 10.1016/j.antiviral.2016.08.011. Epub 2016 Aug 11. Antiviral Res. 2016. PMID: 27523492 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page